Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Teva Pharmaceutical Industries has launched Olanzapine and Fluoxetine Capsules USP 6mg/25mg, 12mg/25mg, 6mg/50mg, and 12mg/50mg.
Subscribe to our email newsletter
The Olanzapine and Fluoxetine Capsules are the company’s generic equivalent to Symbyax.
Lilly USA commercializes Symbyax, which is approved for the acute treatment of treatment-resistant depression and bipolar I depression in adults.
According to IMS sales data, Symbyax had annual sales of approximately $82m in the US.
Teva is a global pharmaceutical company with a focus on CNS, oncology, pain, respiratory and women’s health therapeutic areas as well as biologics.